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Introduction {#sec1}
============

Despite their small genomes, influenza A viruses (IAVs) dedicate multiple proteins to the suppression of host gene expression, or "host shutoff," which limits host antiviral responses. One of these IAV host shutoff proteins is the endoribonuclease PA-X, which selectively degrades host RNAs ([@bib43], [@bib49]) and limits innate immune responses *in vivo*. PA-X-deficient viruses induce stronger innate immune and inflammatory responses in mice, chickens, and pigs ([@bib25], [@bib29], [@bib33], [@bib39], [@bib40], [@bib43], [@bib78]). In some IAV strains, the immune-evasion activity of PA-X reduces inflammation-induced pathology, thereby protecting the host and reducing mortality ([@bib25], [@bib29], [@bib39], [@bib40], [@bib43]). While the role of PA-X in immune evasion is well established, its molecular mechanism of action remains poorly understood.

PA-X is produced by ribosomal frameshifting during the translation of the polymerase acidic protein (PA) mRNA ([@bib22], [@bib43]). The frameshift generates a protein with the PA amino-terminal ribonuclease (RNase) domain fused to a unique carboxy-terminal domain known as the X-open reading frame (X-ORF). The X-ORF is required for PA-X function ([@bib34], [@bib49], [@bib64]). Despite this non-canonical production mechanism, PA-X is encoded by all IAV strains ([@bib72]). We previously reported that PA-X selectively degrades RNAs transcribed by host RNA polymerase II (Pol II), but not other polymerases ([@bib49]). This characteristic leads to the protection of viral RNAs created by the viral RNA-dependent RNA polymerase (RdRp) ([@bib49]). However, the mechanism for PA-X targeting of Pol II transcripts is not known.

Other viruses encode host shutoff RNases that selectively target Pol II transcripts, including alphaherpesviral vhs proteins, gammaherpesviral SOX/BGLF5 proteins, and the severe acute respiratory syndrome-related coronavirus (SARS-CoV) non-structural protein 1 (nsp1) ([@bib10], [@bib11], [@bib17], [@bib23], [@bib27], [@bib45], [@bib68]). However, SARS nsp1 and the herpesviral host shutoff proteins operate in the cytoplasm and only degrade transcripts that are bound by components of the protein synthesis machinery ([@bib11], [@bib15], [@bib19], [@bib20], [@bib23], [@bib46]). By contrast, PA-X accumulates in the nucleus, and the protein synthesis machinery has no role in RNA targeting and degradation ([@bib34], [@bib49]). Our previous analysis of select transcripts suggests that not all Pol II transcripts are equally susceptible to PA-X degradation ([@bib49]), similar to reports for other viral host shutoff RNases ([@bib18], [@bib28]). In agreement with this, a recent study of the host transcriptome in IAV-infected cells showed that certain functional classes of RNAs were spared from shutoff, although no specific link to PA-X activity was established ([@bib7]). By contrast, in the context of studying the relative contribution of IAV PA-X and NS1 proteins to host shutoff, Toru Takimoto's group recently reported that host mRNAs targeted by PA-X do not clearly belong to specific functional classes, whereas there is functional specificity among NS1 targets ([@bib8]). These findings suggest that PA-X may have a unique mechanism to selectively target host RNAs in the nucleus, perhaps in conjunction with RNA processing and the assembly of functional messenger ribonucleoprotein (mRNP) complexes.

Here, we report transcriptome-wide analysis of PA-X targets in human lung A549 cells, in both *de novo* infection and ectopic expression models. This analysis revealed that PA-X susceptibility is tightly linked to Pol II transcript splicing. Moreover, we identified host proteins involved in mRNA processing that associate with the C-terminal X-ORF, suggesting that PA-X target selection may involve physical interactions with components of the host mRNA processing machinery.

Results {#sec2}
=======

PA-X Causes Global Changes in RNA Levels during Infection {#sec2.1}
---------------------------------------------------------

To determine the scope of PA-X specificity for host Pol II transcripts, we profiled RNA levels in cells infected with wild-type (WT) and PA-X-deficient IAVs. To generate PA-X-deficient mutants in the well-characterized strain A/PuertoRico/8/1934 H1N1 (PR8), we introduced 2 mutations in the frameshifting site and a nonsense mutation in PA-X, L201Stop, that truncated the X-ORF after 9 amino acids (aa); we called this virus PA(ΔX) ([Figure 1](#fig1){ref-type="fig"} A). These mutations were designed to be silent in the PA ORF. We previously used a strain with only the frameshifting mutations, IAV PA(fs) ([Figure S1](#mmc1){ref-type="supplementary-material"}A) ([@bib49]), but we created IAV PA(ΔX) to ensure that any residual frameshifting would produce a non-functional PA-X. We confirmed that the 9-aa truncated PR8 PA-X was largely inactive, as it lost the ability to degrade a β-globin reporter, whereas an X-ORF truncation to 15 aa retained activity ([Figure 1](#fig1){ref-type="fig"}B). The β-globin reporter includes the two introns of the native β-globin gene, and expresses an mRNA that is spliced. The results in [Figure 1](#fig1){ref-type="fig"}B recapitulate previous findings using truncations in PA-X variants from other strains ([@bib34], [@bib64]). We also generated a virus with only the L201Stop mutation and called it "X9" ([Figure S1](#mmc1){ref-type="supplementary-material"}A). We chose to use the PR8 strain because it lacks two other known IAV host shutoff mechanisms; its NS1 protein does not block host mRNA processing ([@bib13], [@bib70]), and its RdRp does not trigger Pol II degradation ([@bib66]).Figure 1PA-X Downregulates Most Cellular RNAs and Is a Major Contributor to Host Shutoff during Influenza A Virus Infection(A) Diagram of mutations in the PR8 PA(ΔX) virus. Less intense colors indicate lower levels of PA-X. Blue, position of the frameshift. Red, mutated nucleotides in the frameshifting sequence and at PA-X codon 201.(B) HEK293T cells were transfected for 24 h with a β-globin reporter and WT PR8 PA-X ("61") or variants with the C-terminal X-ORF truncated after the indicated number of amino acids (aa). Levels of β-globin in PA-X transfected cells were measured by RT-qPCR and are plotted relative to vector transfected cells, after normalization to cellular 18S rRNA. Values represent means ± SDs. n = 3. ^∗^p \< 0.05, and ^∗∗^p\< 0.01, ANOVA followed by Dunnett's multiple comparison test versus WT PA-X (61 aa).(C) RNA-seq was carried out on RNA collected 15 h after infection from A549 cells infected with WT PR8 or PR8 PA(ΔX). The ratio between levels in IAV-infected versus mock-infected cells was computed for each RNA and the distribution of the ratios (log2) is plotted as a frequency histogram. The populations are significantly different (p \< 0.001) based on the Kolmogorov-Smirnoff test. The dashed line indicated a ratio of 1 (no change). n ≥ 2.(D) The ratio in RNA levels in WT IAV-infected cells versus mock-infected cells in our study (15 h post-infection, MOI = 1) is plotted against the results from [@bib7] (8 h post-infection, MOI = 5). p \< 0.001, Spearman's test.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Using high-throughput RNA sequencing (RNA-seq), we found that the infection of cells with WT IAV caused a dramatic global decrease in transcript levels compared to mock-infected cells ([Figure 1](#fig1){ref-type="fig"}C; [Data S1](#mmc3){ref-type="supplementary-material"}). However, a small fraction of transcripts escaped shutoff (right tail end of distribution; [Figure 1](#fig1){ref-type="fig"}C). By contrast, shutoff was substantially attenuated in IAV PA(ΔX)-infected cells. Cells infected with strains carrying either the PA(X9) or PA(fs) mutations also displayed attenuated host shutoff, and the defect was similar in all three mutants ([Figure S1](#mmc1){ref-type="supplementary-material"}B). This demonstrates that X-ORF truncation disrupts PA-X function during infection, as predicted from ectopic PA-X expression studies ([@bib34], [@bib49], [@bib64]). Infection rates by WT and mutant viruses were comparable, based on immunofluorescence staining and viral protein levels ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). We also measured the nuclear accumulation of cytoplasmic poly(A) binding protein (PABP), a well-described consequence of host shutoff ([@bib48], [@bib52], [@bib53], [@bib55]). Infection with PA(X9) and PA(ΔX) viruses resulted in significantly lower rates of PABP nuclear accumulation compared to WT, confirming the impairment of host shutoff ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2C). Lastly, our RNA-seq results strongly correlated with those from a previous transcriptome profile of IAV PR8-infected cells ([@bib7]), despite the differences in multiplicity of infection (MOI) and time course of analysis ([Figure 1](#fig1){ref-type="fig"}D). These data demonstrate that PA-X controls the levels of the majority of host RNAs during infection.

PA-X Causes Global Downregulation of Host RNAs in an Ectopic Expression Model {#sec2.2}
-----------------------------------------------------------------------------

To simplify our system, we also examined changes in RNA levels after ectopic PA-X expression. We used a doxycycline-inducible PA-X expression system, "iPA-X" cells ([@bib49]), to induce the expression of WT PA-X or the catalytically inactive D108A mutant in A549 cells. Because iPA-X cells were clonally selected, we analyzed 2 independently generated cell lines for each variant. As expected from previous results with targeted RT-qPCR and metabolic labeling ([@bib33], [@bib43], [@bib49]), WT PA-X robustly downregulated steady-state transcript levels ([Figure 2](#fig2){ref-type="fig"} A; [Data S2](#mmc4){ref-type="supplementary-material"}). The degree of host shutoff correlated with the levels of PA-X (percentage of total reads mapping to PA-X: WT \#1 = 0.005%--0.006%, WT \#10 = 0.023%--0.026%) and was dependent on RNase activity, because expression of the PA-X catalytic mutant had no effect ([Figure 2](#fig2){ref-type="fig"}A). A substantial minority of transcripts was unaffected by PA-X expression (right tail end of distributions; [Figure 2](#fig2){ref-type="fig"}A). Furthermore, we observed a highly significant correlation between the PA-X-dependent downregulation of RNAs in the ectopic PA-X expression system and in virus-infected cells ([Figure 2](#fig2){ref-type="fig"}B). This indicates that PA-X largely targets the same RNAs in the absence of other viral proteins and that the ectopic expression model accurately reflects the contribution of PA-X to host shutoff during infection. To further validate these findings, we selected representative RNAs, choosing RNAs that were strongly downregulated (glyceraldehyde-3-phosphate dehydrogenase \[GAPDH\], glucose-6-phosphate dehydrogenase \[G6PD\]) or largely unaffected (heterogeneous nuclear ribonucleoprotein A0 \[HNRNPA0\], TATA-box binding protein associated factor 7 \[TAF7\], enhancer of polycomb homolog 1 \[EPC1\]) in both *de novo* infection and ectopic expression models. We then validated the change in RNA levels in iPA-X cells by RT-qPCR. The RT-qPCR results agreed with the RNA-seq data in terms of the selective effects on the tested transcripts ([Figure 2](#fig2){ref-type="fig"}C). By contrast, doxycyline-inducible expression of the catalytically inactive PR8 PA-X D108A mutant or the PA-X RNase domain (aa 1--191, "N term") did not affect the level of any of the tested transcripts ([Figure 2](#fig2){ref-type="fig"}C). Expression of PA-X or the RNase domain was confirmed by western blotting ([Figure 2](#fig2){ref-type="fig"}D). Because the RNase domain alone is active *in vitro* ([@bib6], [@bib14], [@bib81]), this result confirms that it is specifically the activity of PA-X and not the overexpression of any active RNase that controls RNA levels in the iPA-X cells. Moreover, the mRNA levels were similarly affected by the expression of PA-X from the A/Udorn/72 H3N2 (Udorn) strain, suggesting that target selection by PA-X is conserved among virus strains ([Figure 2](#fig2){ref-type="fig"}C). These data demonstrate that PA-X broadly targets RNA for degradation, while a subset of RNAs remains unaffected.Figure 2PA-X Downregulates Most Cellular RNAs in the Absence of Other Viral ProteinsRNA and protein samples were collected from control (untransduced) A549 cells or A549 cells expressing doxycycline-inducible PR8 PA-X (WT), PR8 PA-X catalytic mutant (D108A), PR8 PA-X N-terminal endonuclease domain (aa 1--191, "N term"), or Udorn PA-X 18 h after the addition of doxycycline.(A) RNA-seq was carried out on cells expressing WT or mutant PR8 PA-X (2 clonal lines for each). The ratio between the levels in PA-X-expressing versus control cells was computed for each RNA, and the distribution of the ratios is plotted as a frequency histogram. The dashed line indicates a ratio of 1 (no change). n ≥ 2.(B) The PA-X-dependent changes in RNA levels in infected cells (ratio in PR8 PA(ΔX) versus WT PR8) are plotted against changes in cells expressing PR8 PA-X versus control cells. p \< 0.001, Spearman's test.(C) Levels of several endogenous mRNAs were measured by RT-qPCR in cells expressing the indicated PA-X variants. After normalization to 18S, mRNA levels are plotted relative to uninduced cells. Values represent means ± SDs. n ≥ 3. ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001. ANOVA followed by Dunnett's multiple comparison test versus PR8 PA-X D108A.(D) A representative western blot using anti-myc antibodies to detect myc-tagged PA-X and a total protein stain as loading control (blot section from 25 to 35 kDa) shows successful induction of PA-X in each cell line (corresponds to one of the experiments shown in C).

Specific Functional Classes of Host RNAs Are Differentially Sensitive to PA-X {#sec2.3}
-----------------------------------------------------------------------------

Although most RNAs were downregulated by PA-X, the levels of ∼25% of RNAs remained largely unchanged ([Figures 1](#fig1){ref-type="fig"}C and [2](#fig2){ref-type="fig"}A). To identify resistant RNAs, we used *k*-means clustering to group RNAs with similar patterns of regulation ([@bib26]). Clustering was carried out based on the relative RNA levels in PA-X-overexpressing (OE) cells versus control cells or IAV- versus mock-infected cells in our 8 datasets ([Figures 1](#fig1){ref-type="fig"}C, [2](#fig2){ref-type="fig"}A, and [S1](#mmc1){ref-type="supplementary-material"}B). Two sets of RNAs making up 55% of the RNAs that were detected in all conditions were identified as true PA-X targets ([Figure 3](#fig3){ref-type="fig"} A; [Data S1](#mmc3){ref-type="supplementary-material"}a and [S2](#mmc4){ref-type="supplementary-material"}a). These RNAs were downregulated in a PA-X-dependent manner both during infection and by PA-X ectopic expression. The RNAs in the first set were completely PA-X-specific, as their levels were largely unchanged in IAV PA(ΔX)-infected cells ([Figure 3](#fig3){ref-type="fig"}A, left). The RNAs in the second set were PA-X sensitive, but were partially downregulated by other mechanisms during IAV PA(ΔX) infection ([Figure 3](#fig3){ref-type="fig"}A, right). By contrast, 28% of the RNAs were PA-X resistant and were not downregulated by infection or PA-X expression ([Figure 3](#fig3){ref-type="fig"}B; [Data S1](#mmc3){ref-type="supplementary-material"}b and [S2](#mmc4){ref-type="supplementary-material"}b). In addition, the *k-*means algorithm identified a group of RNAs that were downregulated during infection by a PA-X-independent mechanism and yet were PA-X sensitive in PA-X-expressing cells ([Figure 3](#fig3){ref-type="fig"}C; [Data S1](#mmc3){ref-type="supplementary-material"}c and [S2](#mmc4){ref-type="supplementary-material"}c). The levels of these transcripts may be substantially decreased by other regulatory mechanisms during infection, such that their targeting by PA-X is masked. Based on Gene Ontology (GO) term analysis, the host shutoff-resistant RNAs were significantly enriched for genes involved in transcription and translation, including ribosomal RNA processing, ribosomal proteins, and membrane protein synthesis ([Figure 3](#fig3){ref-type="fig"}D). This result is consistent with the IAV requirement for host biosynthetic machinery and observations by [@bib7]. These results suggest that while PA-X can target many RNAs, it retains some specificity for functional classes of RNAs.Figure 3*k*-Means Clustering Reveals Differentially Regulated Groups of RNAs(A--C) Cluster 3 was used to divide cellular RNAs in 4 clusters based on the pattern of fold changes in iPA-X cells (PA-X WT or D108A catalytic mutant versus control) and cells infected with IAV (WT or PA-X-deficient IAV versus mock). Cumulative probability histograms of fold changes for each of the classes are plotted: (A) 2 groups of PA-X targets, (B) PA-X-resistant RNAs, (C) potential PA-X targets that are regulated by other processes during infection. All of the datasets collected were used for clustering, but only select datasets are plotted for simplicity.(D) DAVID was used to identify overrepresented Gene Ontology (GO) terms for biological processes and molecular functions among PA-X-resistant RNAs. Fold enrichment is plotted for GO terms that had corrected p \< 0.01.(E) Pie charts showing the percentage of genes that are up- and downregulated in infected and iPA-X cells. Left: all RNAs detected in RNA-seq (WT versus mock: N = 8,573, PR8 PA(ΔX) versus mock: N = 8,848, PA-X overexpression (OE) versus control: N = 8,554). Right: interferon-stimulated genes (ISGs; WT versus mock: N = 167, PR8 PA(ΔX) versus mock: N = 168, PA-X OE versus control: N = 159).

In addition to this unbiased analysis, we examined how PA-X expression affected the levels of interferon-stimulated genes (ISGs), which are induced in infected cells and function in antiviral defense ([@bib71]). We observed that although ISGs were induced during IAV infection, as shown by their higher expression compared to all of the detected RNAs, their levels were even higher in the absence of PA-X ([Figure 3](#fig3){ref-type="fig"}E). While the activity of PA-X is clearly not limited to ISGs, these data indicate that PA-X can contribute to dampening the cell-intrinsic response to infection.

PA-X Strongly and Preferentially Downregulates Spliced Pol II Transcripts {#sec2.4}
-------------------------------------------------------------------------

We previously showed that PA-X selectively degrades RNA transcribed by Pol II and spares Pol I and Pol III transcripts ([@bib49]). Although all cellular transcripts are modified post-synthesis, only Pol II transcripts can be spliced. The process of RNA splicing is mechanistically linked to transcription, as recruitment of the spliceosome is mediated by the C-terminal domain of the large subunit of Pol II ([@bib30]). However, a subset of Pol II transcripts naturally lacks introns. When we analyzed spliced versus intronless RNAs separately, we found that PA-X downregulated spliced RNAs more than intronless RNAs ([Figure 4](#fig4){ref-type="fig"} A). Our targeted validation also showed that two intronless mRNAs, TAF7 and HNRNPA0, were not downregulated by PA-X ([Figure 2](#fig2){ref-type="fig"}C), and, as mentioned above, the β-globin reporter used in [Figure 1](#fig1){ref-type="fig"}B encodes a spliced mRNA. Moreover, during infection, the downregulation of spliced RNAs was clearly dependent on PA-X, whereas most of the downregulation of intronless RNAs was PA-X independent ([Figure 4](#fig4){ref-type="fig"}B). For these analyses, we only included intronless RNAs longer than 300 nt, excluding small non-coding RNAs and ensuring that the length distribution was similar between spliced and intronless RNAs. We also analyzed how the number of exons affected RNA downregulation, as the number of splice sites varies dramatically among spliced RNAs. There was a significant negative correlation between the number of exons in a transcript and its steady-state levels in PA-X-expressing and infected cells (PA-X-expressing cells: Spearman's ρ = −0.52, [Figure 4](#fig4){ref-type="fig"}C; IAV-infected cells: Spearman's ρ = −0.47, [Figure S3](#mmc1){ref-type="supplementary-material"}A). This result suggests that RNAs with more exons are more susceptible to PA-X degradation. However, the number of exons in an RNA is often proportional to RNA length. A prior study reported a relation between IAV host shutoff and transcript length ([@bib7]). Likewise, there was a correlation between degradation and RNA length in our data (Spearman's ρ = −0.38 for both PA-X-expressing \[[Figure 4](#fig4){ref-type="fig"}D\] and IAV-infected cells \[[Figure S3](#mmc1){ref-type="supplementary-material"}B\]). To determine whether exon number or transcript length was important, we examined RNAs of similar length or with a specific number of exons. We still found a robust negative correlation between relative RNA levels in the presence of PA-X and exon number among RNAs of similar length (length = 3.5--4.0 kb, Spearman's ρ = −0.42, N = 674; [Figure 4](#fig4){ref-type="fig"}E). Similar correlations were also seen for RNAs of other lengths ([Figure S3](#mmc1){ref-type="supplementary-material"}C). By contrast, there was only a small correlation between degradation and RNA length among RNAs with the same number of exons (number of exons = 6, Spearman's ρ = −0.16, N = 642; [Figure 4](#fig4){ref-type="fig"}F). Again, similar correlations were seen for other exon numbers ([Figure S3](#mmc1){ref-type="supplementary-material"}D). We also tested another key characteristic of RNAs, guanine-cytosine (GC) content, and found no correlation with PA-X activity in our dataset ([Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F).Figure 4RNAs that Are Not Spliced Are Less Sensitive to Regulation by PA-X(A and B) RNA-seq results from [Figures 1](#fig1){ref-type="fig"}C and [2](#fig2){ref-type="fig"}A are plotted separately for spliced and intronless RNA as cumulative distribution histograms. (A) Cells overexpressing WT PA-X, clones \#1 and \#10; (B) cells infected with WT PR8 versus PR8 PA(ΔX).(C--F) Relative RNA levels in PA-X overexpressing (OE; clone \#1) versus control cells are plotted against the number of exons (C and E, log2 scale) or transcript length in kilobases (D and F, log10 scale). (C and D) All RNAs, (E) RNAs with 6 exons, and (F) RNAs 3.5--4.0 kb in length. All of the correlations are statistically significant (p \< 0.001, Spearman's test).(G) The number of exons for RNAs identified in the clustering analysis ([Figure 3](#fig3){ref-type="fig"}) is plotted. The two groups of PA-X targets ([Figure 3](#fig3){ref-type="fig"}A) are plotted together. p \< 0.01, Kolmogorov-Smirnoff test.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

The results from the clustering and GO analyses ([Figures 3](#fig3){ref-type="fig"}A--3D) suggest that PA-X differentially regulates RNAs from specific functional groups, whereas [Figures 4](#fig4){ref-type="fig"}A--4F suggest a difference based on the structure of the nascent transcript. Interestingly, we found a connection between the structural and functional specificity. RNAs classified as resistant by *k-*means clustering (shown in [Figure 3](#fig3){ref-type="fig"}B) had fewer exons than those classified as PA-X targets (shown in [Figure 3](#fig3){ref-type="fig"}A) ([Figure 4](#fig4){ref-type="fig"}G). These results suggest that targeting by PA-X is connected to RNA splicing and that this preference has consequences for the selection of functionally relevant targets.

Splice Sites Confer Susceptibility to PA-X {#sec2.5}
------------------------------------------

Endogenous RNAs with different numbers of exons also have different sequences, lengths, and post-transcriptional modifications. To investigate the effect of splicing in a more controlled system, we examined the same RNA in both spliced and intronless forms. We used interferon λ2 (IFN-λ2) mRNA as a model transcript. IFN-λ2 is a type III IFN that contributes to IAV immune responses ([@bib44]). In the RNA-seq, IFN-λ2 transcripts were detectable only in IAV-infected cells and were downregulated by PA-X ([Figure S4](#mmc1){ref-type="supplementary-material"}A). We cloned the IFN-λ2 cDNA and the full IFN-λ2 genomic sequence containing introns into plasmid expression vectors ([Figure 5](#fig5){ref-type="fig"} A) and co-transfected them into HEK293T cells with PR8 PA-X. In these transfection experiments, the detection of PA-X protein is hindered by auto-cleavage of the PA-X Pol II transcript. As an alternative control to ensure comparable PA-X activity between transfections, we also measured the RNA levels of a co-transfected intron-containing luciferase reporter ([@bib80]); luciferase downregulation thus serves as a positive control for PA-X activity ([Figures 5](#fig5){ref-type="fig"}B--5D, and 5G). We confirmed that IFN-λ2 mRNA was expressed and exported to the cytoplasm at similar levels, irrespective of the construct used ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). We also checked that the 5 introns were properly spliced by PCR analysis ([Figures 5](#fig5){ref-type="fig"}E, 5F, and [S4](#mmc1){ref-type="supplementary-material"}D). As expected, we found that PA-X downregulated the IFN-λ2 mRNA expressed from the full genomic region ([Figure 5](#fig5){ref-type="fig"}B). However, the levels of the same IFN-λ2 mRNA expressed from an intronless cDNA construct were only minimally reduced ([Figure 5](#fig5){ref-type="fig"}B). In both conditions, the control luciferase reporter was downregulated by PA-X, confirming that the activity of PA-X was similar in all of the samples. PA-X proteins from the 2009 pandemic H1N1 strains (e.g., A/California/7/09H1N1 \[CA/7\] and A/Tennessee/1-560/2009) and the Udorn H3N2 strain also preferentially degraded the spliced mRNAs ([Figure 5](#fig5){ref-type="fig"}C). These results confirm the prediction that splicing is important for PA-X targeting. In addition, we tested the downregulation of IFN-λ2 mRNAs expressed from chimeric constructs that contained only 1 of the 5 introns from the original genomic sequence to determine whether a single splicing event was sufficient to restore PA-X targeting. Addition of a single intron increased susceptibility to PA-X ([Figure 5](#fig5){ref-type="fig"}D). Downregulation of the luciferase reporter indicated that these changes were not due to varying PA-X activity in the samples. We found that while the addition of introns 1, 3, or 5 alone restored PA-X susceptibility, introns 2 or 4 had little effect. The difference between the introns was also apparent when we normalized IFN-λ2 to luciferase mRNA levels ([Figure S4](#mmc1){ref-type="supplementary-material"}E). Intron 4 was not spliced efficiently in the absence of other introns ([Figure 5](#fig5){ref-type="fig"}E), but intron 2 was still efficiently spliced ([Figure 5](#fig5){ref-type="fig"}F). Therefore, splicing efficiency alone does not explain the differential effects of the introns. More in-depth examination of the IFN-λ2 sequence revealed that the 5′ splice sites for introns 1, 3, and 5 match the consensus 5′ splice site sequence, AG\|GT (where \| marks the splice site). By contrast, the 5′ splice sites for introns 2 and 4 are an imperfect match (TA\|GT and GT\|GT, respectively). 5′ splice-site quality scores calculated using the MaxEntScan::score5ss program were also higher for introns 1, 3, and 5 (8.8--10.5) than introns 2 and 4 (5.8) ([@bib79]). When we mutated these two 5′ splice sites to match the consensus sequence AG\|GT and increase the splice site quality score (mutated introns 2 and 4 = 10.7), we found that the mutated introns 2 and 4 could restore PA-X susceptibility ([Figures 5](#fig5){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}F normalized to luciferase mRNA levels) and intron 4 splicing efficiency ([Figure 5](#fig5){ref-type="fig"}E). This result further strengthens the link between splicing and PA-X susceptibility.Figure 5Addition of Introns and Splicing Events Promotes Degradation by PA-X(A) Diagram of IFN-λ2 constructs. Int, intron.(B--G) HEK293T cells were transfected for 24 h, with reporters expressing a luciferase control mRNA and IFN-λ2 mRNA from cDNA, the genomic locus, cDNA with 1 of the 5 IFN-λ2 introns added back, or cDNA with IFN-λ2 introns 2 or 4 carrying mutations that restore a canonical 5′ splice site sequence. Cells were also transfected with PA-X (PR8 variant in B, D, and G; PR8, CA/7, and Udorn variants in C) or vector. Levels of luciferase and IFN-λ2 mRNAs were measured by RT-qPCR and plotted as relative levels in PA-X expressing versus vector-transfected cells, after normalization to 18S rRNA. The downregulation of a spliced luciferase mRNA serves as a control to ensure similar PA-X activity across samples. In (E) and (F), cDNA from vector-transfected cells was PCR amplified across the indicated introns to test splicing. Amplified PCR products are shown (image is representative of 4 experiments). A 1:1 mix of the IFN-λ2 cDNA and genomic constructs was included to check that unspliced and spliced products could be simultaneously amplified.(H) Cells were transfected with an intronless (−) or an intron-containing (+ intron) luciferase reporter and PR8 PA-X. Luciferase RNA levels were measured by RT-qPCR, normalized by 18S rRNA, and were plotted relative to vector-transfected cells.Values represent means ± SDs; n ≥ 4. ^∗^p \< 0.05, ^∗∗^p \< 0.01; For (B) and (C), ANOVA followed by Tukey's pairwise test; (D) ANOVA followed by Dunnett's test, p values relative to cDNA construct; (H) Student's t test.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Despite these results linking mRNA splicing and PA-X degradation, one unresolved issue is that we and others have previously used intronless reporters to study PA-X, and they appeared to be efficiently degraded. To investigate this issue, we compared intronless and spliced luciferase reporters ([@bib80]). The spliced reporter, which we used as a control in [Figures 5](#fig5){ref-type="fig"}B--5G, contains a portion of the β-globin intron ([@bib80]). PA-X had a more robust effect on the spliced mRNA, although it could also downregulate intronless luciferase mRNA ([Figures 5](#fig5){ref-type="fig"}H and [S4](#mmc1){ref-type="supplementary-material"}G). These results suggest that the addition of a single splicing event further promotes degradation by PA-X. Reporter constructs are selected for their robust expression; it is possible that certain intronless reporters also associate with cellular factors involved in PA-X targeting. Nevertheless, our findings lead us to recommend the use of intron-containing reporters for future cell-based studies of PA-X.

The X-ORF Mediates Interaction with Proteins Involved in RNA Metabolism {#sec2.6}
-----------------------------------------------------------------------

As shown in previous studies ([@bib34], [@bib49], [@bib64]) and the PR8 PA(X9) RNA-seq results ([Figure S1](#mmc1){ref-type="supplementary-material"}B), the C-terminal X-ORF is required for PA-X activity. We hypothesized that the X-ORF interacts with cellular proteins that mediate the association of PA-X with target mRNAs, especially in light of our results connecting PA-X targeting with splicing ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}) and mRNA 3′ end processing ([@bib49]). To identify cellular X-ORF-interacting proteins, we used BioID, a proteomic technique that relies on non-specific proximity biotinylation of lysine residues by a modified *Escherichia coli* biotin ligase, BirA^∗^ ([@bib67]). Since there are two major classes of PA-X isoforms that differ in X-ORF length ([@bib72]), we fused BirA^∗^ to X-ORFs representative of each class: the 61-aa PR8 X-ORF (X61) and the 41-aa CA/7 X-ORF (X41) ([Figure 6](#fig6){ref-type="fig"} A). We used BirA^∗^ alone and BirA^∗^ fused to a mutated PR8 X-ORF in which 4 positively charged residues were replaced by alanine (X61(4A)) as negative controls. These mutations prevent the nuclear localization of a GFP-X-ORF fusion and disrupt mRNA degradation by PA-X ([@bib49]). As expected from our previous studies ([@bib49]), fusion to the WT X-ORFs, but not X61(4A), led to the accumulation of BirA^∗^ in the nucleus ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Moreover, all BirA^∗^ fusions efficiently biotinylated many cellular proteins ([Figure S5](#mmc1){ref-type="supplementary-material"}B).Figure 6The X-ORF Interactome Is Enriched for Proteins Involved in mRNA Processing(A) Schematic diagram of X-ORF-BirA^∗^ fusion baits used in the BioID mass spectrometry experiment. The numbers indicate independent runs using each construct set. Light, medium, and heavy = light, medium, or heavy isotope tags.(B) Overlap between proteins identified by mass spectrometry by ≥2 unique peptides in 3 BioID runs.(C) Average relative abundance of 286 proteins identified in at least 2 BioID experiments, plotted as log2 ratio of medium versus light (x axis, X-ORF/−) and medium versus heavy (y axis, X-ORF/X61(4A)). Green dots represent proteins with \>1.5-fold enrichment over both negative controls; blue dots represent proteins with \>1.5-fold enrichment over BirA^∗^-myc alone; black and red open circles represent high-confidence hits (\>2.0-fold over BirA^∗^-myc in ≥2 experiments or \>1.5-fold over BirA^∗^-myc and BirA^∗^-X61(4A)-myc in 3 experiments); red open circles represent nucleolin (NCL) and nucleophosmin (NPM1), which were enriched \>2.0-fold over both negative controls in all 3 experiments.(D) STRING protein-protein interaction network of high-confidence hits. Apparent nodes were differentially colored (only 1 annotation per protein is shown for simplicity).(E) Gene Ontology (GO) enrichment analysis of X-ORF BioID hits (black and red circles in C). All enriched functional classes are presented (excluding parental subclasses for each term). Note that the \>100-fold enriched functional classes contain only 2 proteins each.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

To identify cellular proteins that bind both the X61 and X41 X-ORFs, we affinity-purified biotinylated proteins from HEK293T cells expressing BirA^∗^-X-ORF fusion proteins and prepared them for quantitative mass spectrometry using reductive dimethylation. Reductive dimethylation exploits formaldehyde variants with different molecular weights due to substituted carbon-13 or deuterium atoms to label captured proteins with stable isotope tags and allow quantitative comparisons among samples ([@bib37]). We performed the experiment 3 times---twice with BirA^∗^-X61 and once with BirA^∗^-X41---comparing them in each case to the BirA^∗^ alone and BirA^∗^-X61(4A) controls ([Figure 6](#fig6){ref-type="fig"}A). A total of 156 candidate X-ORF-interacting proteins were represented by at least 2 unique peptides ([Table S4](#mmc2){ref-type="supplementary-material"}) and were present in all of the runs ([Figure 6](#fig6){ref-type="fig"}B). Among these, we selected 29 high-confidence interacting proteins with higher relative peptide abundance in the test (BirA^∗^-X61 or -X41) versus control (BirA^∗^-X61(4A) or BirA^∗^ alone) conditions (\>2-fold higher than controls in at least 2 experiments or \>1.5-fold in all 3 experiments; [Figure 6](#fig6){ref-type="fig"}D; [Table S4](#mmc2){ref-type="supplementary-material"}). [Figure 6](#fig6){ref-type="fig"}C depicts the relative peptide abundance of proteins in X61 samples compared to the X61(4A) control or the BirA^∗^ alone control, with black and red open circles identifying the high-confidence hits. Red circles indicate 2 proteins (nucleolin \[NCL\], nucleophosmin \[NPM1\]) that were enriched \>2-fold compared to controls across all 3 runs. Because NCL and NPM1 are abundant proteins that traffic in and out of nucleoli, these interactions may explain the apparent nucleolar accumulation of biotinylated proteins ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5C), even though neither the BirA-X-ORF fusion ([Figure S5](#mmc1){ref-type="supplementary-material"}A) nor the full-length PA-X ([@bib48], [@bib49]) accumulate in nucleoli. A STRING protein-protein interaction network analysis of the hits revealed several physical and functional interaction nodes, including protein trafficking, transcription, translation, and mRNA processing ([Figure 6](#fig6){ref-type="fig"}D). Similarly, GO term analysis revealed a strong association with mRNA processing, RNA splicing, and mRNA metabolic process functions among the high-confidence hits ([Figure 6](#fig6){ref-type="fig"}E). These data show that the PA-X C-terminal X-ORF is physically recruited to protein complexes involved in nuclear Pol II RNA processing (commonly referred to as mRNA processing), which likely explains the preferential degradation of RNAs that have undergone co- or post-transcriptional processing.

The CFIm Complex May Regulate PA-X Activity {#sec2.7}
-------------------------------------------

The BioID screen identified several proteins involved in RNA splicing (RNA binding motif protein 39 \[RBM39\], poly(U) binding splicing factor 60 \[PUF60\], and pre-mRNA processing factor 4 \[PRPF4\]) and/or polyadenylation (nudix hydrolase 21 \[NUDT21\]/ cleavage and polyadenylation specificity factor 5 \[CPSF5\]/ cleavage factor Im 25 \[CFIm25\] and CPSF6/CFIm68) as X-ORF-interacting proteins. We conducted co-immunoprecipitation experiments to validate these interactions using nuclear extracts derived from an HEK293T iPA-X cell line that produces high levels of a myc-tagged PA-X ([@bib49]). We recapitulated the interaction between full-length PA-X and endogenous NUDT21, suggesting that this is a stable interaction that can survive affinity isolation procedures ([Figures 7](#fig7){ref-type="fig"} A and [S6](#mmc1){ref-type="supplementary-material"}A). NUDT21 and CPSF6 assemble into a functional heterotetrameric CFIm complex ([@bib50]) that enhances polyadenylation and guides polyadenylation site choice ([@bib84]). In addition, the CFIm complex is present in the spliceosome and has been proposed to link splicing to polyadenylation during RNA processing ([@bib65], [@bib83]). To test whether the interaction with the CFIm complex was required for PA-X activity, we used small interfering RNAs (siRNAs) to deplete NUDT21 and CPSF6 alone or in combination ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6F). Partial silencing of CFIm proteins reduced PA-X downregulation of IFN-λ2 upon co-transfection in HEK293T cells ([Figure 7](#fig7){ref-type="fig"}B). Moreover, in A549 cells, silencing of the CFIm complex reduced PABP nuclear localization during IAV PR8 infection ([Figures 7](#fig7){ref-type="fig"}C and 7E), a hallmark of PA-X dependent host shutoff ([Figure S2](#mmc1){ref-type="supplementary-material"}; [@bib48]). PABP relocalization was quantified on a per-cell basis to control for unrelated effects of the knockdowns on cell viability and infection rates. In fact, we found that NUDT21 silencing reduced cell viability, and CPSF6 silencing dramatically reduced infection rates ([Figure 7](#fig7){ref-type="fig"}D). We also tested two additional potential interaction partners, NCL and RBM39, in the PABP relocalization assay ([Figures S6](#mmc1){ref-type="supplementary-material"}C and S6E). While NCL silencing had little effect on cell viability, infection rates, and host shutoff, RBM39 silencing reduced cell viability and infection rates ([Figures S6](#mmc1){ref-type="supplementary-material"}C--S6F). We conclude that NCL is unlikely to have a role in PA-X-mediated host shutoff, whereas the effects of RBM39 silencing on cell physiology are too severe to assess its role in PA-X host shutoff. Nonetheless, these data suggest that the RNA processing and spliceosome-associated CFIm complex is required for at least some of the activity of PA-X in cells.Figure 7The CFIm Complex Is Involved in PA-X Activity(A) Proteins were extracted from the nuclei of uninduced or doxycycline-treated HEK293T cells expressing inducible WT PR8 PA-X, and incubated with myc-trap beads to immunoprecipitate PA-X-myc (myc) or control beads (ctrl). Input and immunoprecipitation (IP) samples were resolved by SDS-PAGE and analyzed by western blotting for PA-X-myc, NUDT21, and CPSF6. The image is representative of 3 independent experiments.(B) NUDT21 and CPSF6 were knocked down by siRNA, separately or in combination, in HEK293T cells. For NUDT21, siRNA \#2 was used (see [STAR Methods](#sec4){ref-type="sec"}). For CPSF6, siRNA \#1 was used for knockdown in combination with NUDT21. Cells were then transfected with a reporter expressing IFN-λ2 mRNA from the genomic locus, with and without WT PR8 PA-X. The levels of IFN-λ2 mRNA and 18S rRNA were measured by RT-qPCR. The expression of IFN-λ2 mRNA is plotted relative to vector-transfected cells, after normalization to 18S rRNA.(C--E) NUDT21 and CPSF6 were knocked down by siRNA in A549 cells, using a mixture of 2 siRNAs. Cells were then infected with WT PR8 IAV for 15 h. Infection rates were assessed by staining for IAV proteins and host shutoff by staining for nuclear PABP.(C) Representative immunofluorescence images. Scale bar, 200 μm, indicated as an arrow in the lower left corner.(D and E) change in the fraction of infected cells with nuclear PABP (D) or total cell counts and infected cells (E), relative to control siRNA.Bars are means ± SDs; n ≥ 3. ^∗^p \< 0.05 and ^∗∗∗^p \< 0.001. ANOVA followed by Dunnett's multiple comparison test versus control siRNA.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

A thorough understanding of the molecular mechanism of action of PA-X is required to determine how it selectively degrades host RNAs and limits innate immune response. In this study, we discovered a key aspect of the PA-X mechanism of action: its selectivity for transcripts that are spliced. This coupling to RNA processing sets PA-X apart from other viral host shutoff RNases that target mRNAs in the cytoplasm in association with translation ([@bib10], [@bib15], [@bib19], [@bib20], [@bib23], [@bib46]). Our transcriptomic results show that, as expected, PA-X downregulates many host RNAs, both on its own and in the context of infection. However, some RNAs are less susceptible to PA-X activity, and a key characteristic of these resistant RNAs is that they are intronless or have fewer introns. Moreover, the C-terminal X-ORF of PA-X interacts with many proteins involved in cellular RNA metabolism. We propose a model whereby PA-X associates with a discrete set of RNA metabolism proteins that allows selective targeting of RNAs during transcription or early processing. In this model, RNAs that are not canonically processed, including viral RNAs, are spared.

Our transcriptomic study confirms that the PA-X-dependent downregulation of host protein production ([@bib33], [@bib43]) is due to a reduction in RNA levels, and defines PA-X-dependent and PA-X-independent components of RNA downregulation during infection. The PA-X-independent component is likely due to a recently described generalized reduction in cellular transcription ([@bib5], [@bib35], [@bib82]), because other known modalities of IAV host shutoff are not active in the PR8 strain ([@bib13], [@bib66], [@bib70]). The mechanism of reduced host transcription in IAV-infected cells remains a matter of debate ([@bib5], [@bib35], [@bib82]). However, it is most likely PA-X independent, because transcription is also reduced during infection with influenza B viruses ([@bib5]), which do not encode PA-X ([@bib72]). Our clustering analysis also revealed that some functional classes of RNAs are spared from PA-X degradation, including mRNAs for proteins involved in translation, which agrees with previous results from [@bib7] ([Figure 3](#fig3){ref-type="fig"}D). Our new results suggest that the small number of exons of these mRNAs, particularly RNAs for ribosomal proteins, may explain this phenomenon.

Another general conclusion of our RNA-seq analysis is that PA-X with a 9-aa truncated C-terminal X-ORF is essentially non-functional in the context of infection. The shutoff impairment of IAV PA(X9) is very similar to that of the PA(fs) and PA(ΔX) viruses ([Figure S1](#mmc1){ref-type="supplementary-material"}B), which presumably have reduced PA-X production. This finding validates the results of multiple studies using ectopic PA-X expression models that concluded that at least 15 aa of the X-ORF is required for full RNA degrading activity in cells ([@bib34], [@bib49], [@bib64]), despite *in vitro* activity of the RNase domain in isolation ([@bib6], [@bib14], [@bib81]). Similarly, a 1918 H1N1 chimeric virus with a stop codon after 15 aa had an intermediate host shutoff phenotype between IAV WT and PA(fs) ([@bib43]). The finding that truncating the X-ORF is sufficient to block PA-X activity in the virus is important because single-point mutations in the X-ORF sequence are less disruptive than frameshifting mutations. Thus, viruses carrying X-ORF mutations could be better tools for *in vivo* studies of PA-X function and IAV pathogenesis.

The key unexpected finding from our study is the link between PA-X and splicing. All other viral host shutoff RNases appear to act at some stage of mRNP loading into the translation apparatus. For example, RNA targeting by the alphaherpesvirus protein vhs is linked to physical interactions with translation initiation factors ([@bib15], [@bib19], [@bib20]) and SARS CoV nsp1 only degrades RNAs that are actively translated ([@bib23], [@bib46]). Thus, to our knowledge, there is no other described instance of a host shutoff RNase using splicing as a targeting mechanism. In fact, splicing was reported to protect mRNAs from cleavage by vhs ([@bib69]). The connection between splicing and PA-X degradation is evident from the reduced effect of PA-X on intronless mRNAs ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}), the negative correlation between exon number and degree of degradation by PA-X ([Figures 4](#fig4){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}), and the fact that small changes in the 5′ splice site can affect the susceptibility to degradation by PA-X ([Figures 5](#fig5){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}F). These findings begin to shed light on the specificity of PA-X for Pol II transcripts ([@bib49]). In cellular transcription, the splicing machinery associates with RNAs through interactions with Pol II, and thus only Pol II transcripts are normally spliced ([@bib30]). Protein-protein interactions with splicing factors may thus bring PA-X to its Pol II targets. This idea is corroborated by our proteomic analysis, which shows that the PA-X X-ORF interacts with several splicing regulators (PUF60, RBM39, PRPF4) and spliceosome-associated polyadenylation proteins (the CFIm complex proteins NUDT21 and CPSF6) ([Figure 6](#fig6){ref-type="fig"}). Furthermore, PA-X activity is in part dependent on the CFIm complex ([Figure 7](#fig7){ref-type="fig"}). We speculate that more exons provide more chances for PA-X to be brought to the RNA by these factors, resulting into more efficient turnover of RNAs with more splice sites. Since these proteins do not regulate the processing of all of the mRNAs in the cell to the same extent, PA-X interactions with these proteins could provide an additional mechanism for target discrimination. Further studies will be needed to determine the exact role of these factors.

A targeting strategy based on splicing offers a major benefit to the virus because it provides the ability to easily discriminate between host and viral mRNAs. Viral mRNAs are synthesized by the RdRp, and most of them are not spliced, which renders them "invisible" to PA-X. That said, our published results suggest that even the two viral mRNAs that are spliced (nuclear export protein \[NEP\] and matrix protein 2 \[M2\]) are PA-X resistant ([@bib49]). However, splicing of viral mRNAs is a fundamentally different process, since the splicing machinery needs to be recruited to the RNAs separately from Pol II ([@bib16]). It is possible that viral mRNA splicing does not require the CFIm complex or other PA-X-binding partners, because they are auxiliary components of the host RNA processing machinery. The PA-X splicing-based targeting strategy is more efficient at virus versus host discrimination than the translation-based targeting strategy used by herpesviral host shutoff RNases, which leads to the degradation of viral and host mRNAs alike ([@bib1]). This is likely because viral translation relies on the same machinery as host translation. While herpesviruses can compensate for the degradation of their own RNAs, this self-sacrifice may not work for a virus such as IAV, which has a shorter replication cycle and a small genome with a limited gene expression program.

Our BioID results suggest that the preference for spliced RNAs may be linked to protein-protein interactions between the PA-X X-ORF and cellular factors. The X-ORF is required for PA-X nuclear localization ([@bib34], [@bib49], [@bib64]). However, enforced nuclear localization of the PA-X RNase domain alone does not fully rescue activity ([@bib34]), suggesting that the X-ORF has additional functions. We identified many X-ORF-interacting proteins with various roles in RNA metabolism in addition to a nuclear import protein (importin 7 \[IPO7\]). By examining the X-ORF in isolation, we likely excluded indirect interactions via RNA binding of the RNase domain, as well as interactions that are important for PA rather than PA-X function. Among our hits, two nucleolar proteins, NCL and NPM1, were also reported to interact with H5N1 PA-X ([@bib56]). The fact that biotinylated proteins accumulated in the nucleoli also supports the idea that NCL and NPM1, which traffic to nucleoli, come in contact with the BirA^∗^-fused X-ORF and full-length PA-X ([Figure S5](#mmc1){ref-type="supplementary-material"}C). It is unclear whether PA-X interaction with nucleolar proteins is of functional importance, since silencing NCL had little effect on PA-X-mediated host shutoff in infected cells ([Figures S6](#mmc1){ref-type="supplementary-material"}C--S6F) and PA-X is not localized specifically to this compartment ([Figure S5](#mmc1){ref-type="supplementary-material"}A; [@bib48], [@bib49]). NCL has been reported to protect specific RNAs from degradation by viral host shutoff RNases, including PA-X ([@bib60], [@bib61]). Therefore, the PA-X-NCL interaction may reflect a different role for NCL in regulating RNA homeostasis during infection. By contrast, we found evidence for the involvement of the CFIm complex (NUDT21 and CPSF6) in host shutoff during infection ([Figures 7](#fig7){ref-type="fig"}D and 7E) and PA-X ectopic expression ([Figure 7](#fig7){ref-type="fig"}B). The findings in infected cells must be interpreted with caution because CPSF6 silencing markedly inhibited viral infection ([Figures 7](#fig7){ref-type="fig"}D, 7F, and [S6](#mmc1){ref-type="supplementary-material"}F). It is unclear whether the reduction in infection rates is connected to PA-X function. While the CFIm complex is more commonly studied for its roles in alternative polyadenylation and mRNA 3′ processing ([@bib32]), multiple studies have shown that NUDT21 and CPSF6 are found in purified spliceosome complexes ([@bib65], [@bib83]). This finding has led to the idea that they may also play a role in the coordination of splicing and 3′ processing ([@bib57]). In a previous study, we reported that canonical 3′ end processing may also be linked to PA-X targeting ([@bib49]); the CFIm complex may also explain this connection. Little is known about the function of the CFIm complex, so studying its contribution to PA-X activity and/or IAV infection may advance the understanding of its normal physiological role. Roles for the other candidate PA-X-interacting proteins remain to be explored; such studies may be hindered if these proteins play PA-X-independent roles in the viral replication cycle or in maintaining general cell viability during infection. For example, we found that silencing RBM39, an alternative splicing regulator, had profound negative effects on cell survival and infection rates ([Figures S6](#mmc1){ref-type="supplementary-material"}D--S6F). We also wonder whether the association of PA-X with cellular proteins could compromise their normal function. We did not find dramatic changes in host splicing in our dataset (not shown), but others have reported increased intron retention in cells infected with a PR8 chimeric virus bearing a 1918 NS1 protein ([@bib82]). This discrepancy could be due to the way we set up our sequencing pipeline or to the NS1 variant present in the virus. Because these changes were attributed to NS1 activity, we must be cautious in our assessment of PA-X-dependent and PA-X-independent effects in our system.

It is interesting that both PA-X and the well-known influenza host shutoff factor NS1 interact with nuclear mRNA processing machinery to control gene expression ([@bib62]). Many NS1 variants (but not PR8 NS1) cause host shutoff by binding and inhibiting a component of the 3′ end RNA processing machinery, CPSF30 ([@bib13], [@bib62]). While this convergence could allow the two proteins to coordinate an attack on the host, studies of engineered and naturally evolved viruses suggest that NS1 and PA-X activities are anti-correlated to prevent cytotoxicity. For example, the original 2009 pandemic H1N1 NS1 does not bind CPSF30, nor does it reduce host gene expression ([@bib31]), but the more human-adapted NS1 from currently circulating pandemic H1N1 strains does ([@bib9], [@bib63]). These H1N1 strains have also accumulated mutations that reduce PA-X activity, suggesting that having two highly active host shutoff proteins may impair viral fitness ([@bib63]). A recent study by the Takimoto lab comparing NS1 and PA-X targeting in a 2009 pandemic strain suggests that NS1 and PA-X have overlapping but not identical targets ([@bib8]). NS1 is more clearly directed at downregulation of the innate immune response, whereas PA-X has a broader targeting range ([@bib8]). In general, host mRNA processing may be a hub of regulation for influenza because viral mRNAs are generally not processed by host machinery. Also, interactions with host mRNA processing do not directly compromise Pol II activity, which is required for viral replication ([@bib54]).

Our results affirm the importance of PA-X for the viral replication cycle, as they show that the ability of the virus to regulate host gene expression is severely reduced in the absence of PA-X. Moreover, we have uncovered a unique mechanism of host RNA targeting that can allow PA-X to distinguish not only between host and viral targets but also among cellular targets. For example, the intronless mRNA TAF7, which we examined in [Figures 2](#fig2){ref-type="fig"}B and 2C, is a component of Pol II pre-initiation complexes. Therefore, PA-X selectivity could have repercussions for the viral replication cycle. Through further elucidation of the PA-X mechanism of action, we will gain important insights into how host shutoff allows the virus to usurp host biosynthetic machinery and expand our knowledge of the link between PA-X and IAV pathogenesis.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**CPSF6 (clone F-3)Santa Cruz BiotechnologyCat\#sc-376228; RRID: [AB_10992032](nif-antibody:AB_10992032){#intref0010}NUDT21 (clone 2203C3)Santa Cruz BiotechnologyCat\#sc-81109; RRID: [AB_2153989](nif-antibody:AB_2153989){#intref0015}PABPC1 (clone 10E10)Santa Cruz BiotechnologyCat\#sc-32318; RRID: [AB_628097](nif-antibody:AB_628097){#intref0020}Tubulin (clone H-235)Santa Cruz BiotechnologyCat\#sc-9104; RRID: [AB_2241191](nif-antibody:AB_2241191){#intref0025}Myc tag (clone 9B11)Cell Signaling TechnologiesCat\#2276; RRID: [AB_331783](nif-antibody:AB_331783){#intref0030}NucleophosminCell Signaling TechnologiesCat\#3542; RRID: [AB_2155178](nif-antibody:AB_2155178){#intref0035}Influenza A virusAbcamCat\#ab20841; RRID: [AB_775660](nif-antibody:AB_775660){#intref0040}NucleolinAbcamCat\#ab22758; RRID: [AB_776878](nif-antibody:AB_776878){#intref0045}Firefly luciferaseAbcamCat\#ab21176; RRID: [AB_446076](nif-antibody:AB_446076){#intref0050}IFNL2/IL-28AAbcamCat\#ab109820; RRID: [AB_10859066](nif-antibody:AB_10859066){#intref0055}PUF60Bethyl LaboratoriesCat\#A302-817A; RRID: [AB_10631036](nif-antibody:AB_10631036){#intref0060}RBM39AtlasCat\#HPA001591; RRID: [AB_1079749](nif-antibody:AB_1079749){#intref0065}Anti-mouse secondary coupled to horseradish peroxidaseSouthern BiotechCat\#103005; RRID: [AB_2619742](nif-antibody:AB_2619742){#intref0070}Anti-rabbit secondary coupled to horseradish peroxidaseSouthern BiotechCat\#403005; RRID: [AB_2687483](nif-antibody:AB_2687483){#intref0075}Anti-goat secondary coupled to horseradish peroxidaseSouthern BiotechCat\#616005Anti-goat secondary coupled to Alexa Fluor-488Thermo FisherCat \# A-11055; RRID: [AB_2534102](nif-antibody:AB_2534102){#intref0080}Anti-mouse secondary coupled to Alexa Fluor-555Thermo FisherCat \# A-31570; RRID: [AB_2536180](nif-antibody:AB_2536180){#intref0085}**Bacterial and Virus Strains**Influenza A virus A/Puerto Rico/8/34 H1N1[@bib47]PR8Influenza A virus A/Puerto Rico/8/34 H1N1 PA(fs)[@bib49]PR8 PA(fs)Influenza A virus A/Puerto Rico/8/34 H1N1 PA(X9)This paperPR8 PA(X9)Influenza A virus A/Puerto Rico/8/34 H1N1 PA(ΔX)This paperPR8 PA(ΔX)**Chemicals, Peptides, and Recombinant Proteins**Streptavidin conjugated to Alexa Fluor-488Life Technologies / Thermo Fisher / Molecular ProbesCat \# S32354; RRID: [AB_2315383](nif-antibody:AB_2315383){#intref0090}Streptavidin conjugated to horseradish peroxidaseCell Signaling TechnologiesCat \# 3999; RRID:[AB_10830897](nif-antibody:AB_10830897){#intref0095}Lipofectamine RNAiMAX transfection reagentLife Technologies / Thermo FisherCat \# 13778150TrizolLife Technologies / Thermo FisherCat \# 15596018Turbo DNaseLife Technologies / Thermo FisherCat \# AM2239RNase AQIAGENCat \# 19101HiFi assembly mixNew England BiolabsE5520SpolyethylenimineVWRCat \# 87001-912DoxycyclineFisherBP26531MycTrap magnetic agarose beadsChromoTekCat\# ymta-20; RRID: [AB_2631370](nif-antibody:AB_2631370){#intref0100}Control magnetic agarose beadsChromoTekCat\# bmab-20cOmplete protease inhibitorsRocheCat\# 11873580001Total protein stain for Li-CorLI-COR biosciencesP/N926-11010**Critical Commercial Assays**iScript Reverse Transcription Supermix for RT-qPCRBio-Rad170-8841Quick-RNA miniprep kitZymo ResearchR1050iTaq Universal SYBR® Green SupermixBio-Rad172-5125RNeasy Plus minikitQIAGEN74134ERCC ExFold RNA spike-in mixLife Technologies / Thermo Fisher4456739TruSeq Stranded Total RNA Library Prep Kit with Ribo-Zero HumanIlluminaRS-122-2301High Capacity Neutravidin Agarose BeadsThermo FisherCat \# 29200Pierce Trypsin protease, MS-GradeThermo FisherCat \# 90057**Deposited Data**Raw sequencing data and fold changesThis paper, GEO (NCBI)GEO: [GSE120183](ncbi-geo:GSE120183){#intref0105}**Experimental Models: Cell Lines**Human epithelial kidney cells HEK293AThermo FisherCat \# R70507Human epithelial kidney cells HEK293TATCCATCC CRL-3216Human adenocarcinoma alveolar basal epithelial cells A549ATCCATCC CCL-185Human adenocarcinoma alveolar basal epithelial cells A549 -- inducible PR8 PA-X wt line \#1[@bib49]A549 iPA-X wt \#1Human adenocarcinoma alveolar basal epithelial cells A549 -- inducible PR8 PA-X wt line \#10[@bib49]A549 iPA-X wt \#10Human adenocarcinoma alveolar basal epithelial cells A549 -- inducible PR8 PA-X D108A line \#2[@bib49]A549 iPA-X D108A \#2Human adenocarcinoma alveolar basal epithelial cells A549 -- inducible PR8 PA-X D108A line \#8[@bib49]A549 iPA-X D108A \#8Human adenocarcinoma alveolar basal epithelial cells A549 -- inducible Udorn PA-X wt line \#18This paperA549 iPA-X UdornHuman adenocarcinoma alveolar basal epithelial cells A549 -- inducible PR8 PA-X N terminus (aa 1-191) line \#8This paperA549 iPA-X NtermHuman epithelial kidney cells HEK293T inducible PR8 PA-X wt line \#T7[@bib49]293T iPA-X wt**Oligonucleotides**Control Stealth siRNALife Technologies / Thermo FisherCat \# 12935300NUDT21 Stealth siRNA (\#1)Life Technologies / Thermo FisherCat \# 1299001 - HSS117100NUDT21 Stealth siRNA (\#2) (used for [Figure 7](#fig7){ref-type="fig"}B)Life Technologies / Thermo FisherCat \# 1299001 - HSS117102CPSF6 Stealth siRNA (\#1)Life Technologies / Thermo FisherCat \# 1299001 - HSS117104CPSF6 Stealth siRNA (\#2)Life Technologies / Thermo FisherCat \# 1299001 - HSS117103Nucleolin Stealth siRNALife Technologies / Thermo FisherCat \# 1299001 - HSS106985Nucleolin Stealth siRNALife Technologies / Thermo FisherCat \# 1299001 - HSS106984RBM39 Stealth siRNALife Technologies / Thermo FisherCat \# 1299001 - HSS145210RBM39 Stealth siRNALife Technologies / Thermo FisherCat \# 1299001 - HSS145212Primers for qPCR and splicing assaysThis paperSee [Table S3](#mmc1){ref-type="supplementary-material"}**Recombinant DNA**pCR3.1-PA-X_PR8-myc[@bib48]N/ApCR3.1-PA-X_TN/CA/7-myc[@bib49]N/ApCR3.1-PA-N191_PR8-myc[@bib49]N/ApCR3.1-PA-X_Udorn-mycThis paperN/ApCR3.1-PA-X_15aa_PR8-mycThis paperN/ApCR3.1-PA-X_9aa_PR8-mycThis paperN/ApTRIPZ_PA-X-Nterm (aa 1-191)\_ PR8-mycThis paperN/ApTRIPZ_PA-X_Udorn-mycThis paperN/ApCMV-IFNL2 cDNAThis paperN/ApCMV-IFNL2 genomicThis paperN/ApCMV-IFNL2 intron 1 onlyThis paperN/ApCMV-IFNL2 intron 2 onlyThis paperN/ApCMV-IFNL2 intron 3 onlyThis paperN/ApCMV-IFNL2 intron 4 onlyThis paperN/ApCMV-IFNL2 intron 5 onlyThis paperN/ApCMV-IFNL2 mutated intron 2 onlyThis paperN/ApCMV-IFNL2 mutated intron 4 onlyThis paperN/ApcDNA3.1-myc-BioID2-MCS[@bib67]Addgene \# 74223pCR3.1-BirA^∗^-mycThis paperN/ApCR3.1-BirA^∗^-X61-mycThis paperN/ApCR3.1-BirA^∗^-X61(4A)-mycThis paperN/ApCR3.1-BirA^∗^-X41(CA/7)This paperN/ACMV-LUC2CP/intron/AREGift from Gideon Dreyfuss; [@bib80]N/ACMV-LUC2CP/AREGift from Gideon Dreyfuss; [@bib80]N/ApCDNA3.1-β-globin[@bib11]N/A**Software and Algorithms**Prism 7GraphPadN/ATophat[@bib51], <https://ccb.jhu.edu/software/tophat/index.shtml>V2.1.1Cufflinks[@bib76], <http://cole-trapnell-lab.github.io/cufflinks/>V2.2.1GeneSys (chemiblot imager)SyngeneV1.5.4.0Image Studio 5.2 (LI-COR imager)LI-COR biosciencesV5.2CFX Manager 3.1 programBio-RadN/ASTRING program<https://string-db.org/>, [@bib75]V10.5Cluster3.0[bonsai.hgc.jp/∼mdehoon/software/cluster/software.htm](http://bonsai.hgc.jp/%7Emdehoon/software/cluster/software.htm){#intref0125}N/AMaxEntScan::score5ss[@bib79]N/A<http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html>DAVID Gene Ontology[@bib41], [@bib42],V6.8<https://david.ncifcrf.gov>**Other**Human genome sequence and annotation (.fasta, .gtf)UCSC <https://ccb.jhu.edu/software/tophat/igenomes.shtml>hg19

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and request for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Marta M. Gaglia (<Marta.Gaglia@tufts.edu>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell lines {#sec4.3.1}

Human embryonic kidney cells HEK293A (Thermo Fisher) and HEK293T (ATCC), and human adenocarcinoma alveolar basal epithelial (A549, ATCC) cells were obtained from commercial sources. HEK293A and HEK293T are female and A549 are male. All cell lines and derivatives were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Hyclone) at 37°C and 5% CO~2~. HEK293T_iPA-X-PR8, A549-iPA-X_PR8 and A549-iPA-X-D108A_PR8 were previously described ([@bib49]). A549-iPA-X_Udorn and iPA-X_PR8_Nterm were generated by transducing A549 cells with lentiviruses containing pTRIPZ-PA-X_Udorn-myc and pTRIPZ-PA-X_PR8-Nterm-myc.

Method Details {#sec4.4}
--------------

### Plasmids {#sec4.4.1}

pCR3.1-PA-X-myc (with PR8 PA-X) ([@bib48]), pCR3.1-PA-N191 (PA-X 0 aa) ([@bib49]), pCR3.1-PA-X_TN/CA/7-myc ([@bib49]), pd2GFP-HR ([@bib55]), pCDNA3.1-β-globin (([@bib11]), subcloned from the pcTet2-βwt plasmid ([@bib73])) were previously described. The luciferase constructs with and without the intron were a kind gift from Gideon Dreyfuss ([@bib80]). pHW-PA(X9) and pHW-PA(ΔX) were generated from pHW-193 (kind gift from R. Webby) and pHW-PA(fs) vectors ([@bib49]), respectively, using Phusion site-directed PCR mutagenesis to introduce the TAG stop codon in +1 ORF (synonymous ATT to ATA substitution at PA Ile-201 codon, TTG to TAG substitution at PA-X Leu-201). pCR3.1-PA-X_9aa-myc and pCR3.1-PA-X_15aa-myc were generated from the pCR3.1-PA-X-myc constructs by amplifying the truncated coding region and inserting it into the SalI-MluI sites of a pCR3.1-C-terminal-myc backbone. pCR3.1-PA-X_Udorn-myc was generated by PCR amplifying the 5′ portion of the segment 3 RNA from a PolI-Udorn construct (kind gift from A. Mehle), adding a single nucleotide deletion to shift the frame of the X-ORF, and inserting into the SalI-MluI sites of a pCR3.1-C-terminal-myc backbone. pTRIPZ-PA-X-Nterm-myc and pTRIPZ_PA-X_Udorn-myc were generated by PCR amplifying PA-N191 from pCR3.1-PA-N191-myc and PA-X-Udorn-myc from pCR3.1-PA-X_Udorn-myc, respectively, and inserting these sequences into the backbone of pTRIPZ-RFP_SV40_3′UTR ([@bib49]) after RFP excision with AgeI and ClaI. pCMV-IFN-λ2 cDNA, genomic and single intron constructs were generated by PCR amplifying the full human IFN-λ2 cDNA, the genomic locus, or combinations of fragments of the two, and inserting into the pd2eGFP-N1 construct (Clontech) after the GFP was excised using NheI and NotI. The 5′ splice site of intron 2 or 4 was then mutated from TTA\|GT and TGT\|GT, respectively, to CAG\|GT within the single-intron constructs to generate the intron 2 and 4 mutant constructs. Gibson cloning using HiFi assembly mix (New England Biolabs) was used to make all of these constructs, unless otherwise stated. The expression vector for the biotin ligase from *E. coli* with the R118G mutation BirA^∗^ (pcDNA3.1-myc-BioID2-MCS) ([@bib67]) was obtained from Addgene (\#74223) and the BirA^∗^ ORF was amplified by PCR and inserted into the pCR3.1-myc vector ([@bib47]) between KpnI and EcoRI sites to generate pCR3.1-BirA^∗^-myc. The PCR-amplified X-ORF sequences from pCR3.1-PA-X-myc and pCR3.1-PA-X(4A)-myc ([@bib49]) were inserted in frame with BirA^∗^ ORF using EcoRI and MluI to generate pCR3.1-BirA^∗^-X61-myc and pCR3.1-BirA^∗^-X61(4A)-myc, respectively. X-ORF coding sequence from A/California/7/2009 H1N1 strain was amplified from pHW-C3 vector ([@bib74]) and inserted in frame with BirA^∗^ ORF using EcoRI and XhoI to generate pCR3.1-BirA^∗^-X41(CA/7) vector.

### Cell lines, lentiviral transduction and transfections {#sec4.4.2}

HEK293A, HEK293T, A549 cells and derivatives were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Hyclone) at 37°C and 5% CO~2~. HEK293T_iPA-X-PR8, A549-iPA-X_PR8 and A549-iPA-X-D108A_PR8 were previously described ([@bib49]). A549-iPA-X_Udorn and iPA-X_PR8_Nterm were generated by transducing A549 cells (ATCC) with lentiviruses containing pTRIPZ-PA-X_Udorn-myc and pTRIPZ-PA-X_PR8-Nterm-myc. Lentiviral packaging was carried out using the packaging plasmids psPAX2 and pMD2.G (Addgene \#12260, \#12259). For experiments using iPA-X cells, cells were treated with 0.2 μg/ml doxycycline for 18 h to induce PA-X expression prior to RNA or protein sample collection. For the RNaseq experiments, untransduced A549 cells were also treated with doxycycline to serve as the control. For experiments using IFN-λ2 constructs and the β-globin reporter, HEK293T cells were plated in 24-well or 6-well plates (for fractionation experiments) and transfected with 800 ng/ml total DNA (including 50 ng/ml PA-X construct) using polyethylenimine (PEI). Cells were collected 24 h later for fractionation and/or RNA extraction and purification, and cell lysates for western blot. For siRNA transfections, HEK293T cells were plated in 6-well plates while transfecting 15 nM siRNA (ThermoFisher Scientific) per well using Lipofectamine RNAiMAX reagents (ThermoFisher Scientific). Cells were transfected two days later with 800 ng/ml total DNA (including 50 ng/ml PA-X construct) using PEI, and collected for RNA and protein 24 h later.

### Viruses and infections {#sec4.4.3}

Wild-type influenza A virus A/Puerto Rico/8/1934 H1N1 (PR8) and the mutant recombinant viruses PR8 PA(X9), PR8 PA(fs) and PR8 PA(ΔX) were generated using the 8-plasmid reverse genetic system ([@bib36]) as previously described ([@bib47]). Viral stocks were produced in MDCK cells and infectious titers determined by plaque assays in MDCK cells using 1.2% Avicel overlays as described in Matrosovich et al. ([@bib58]). A549 cell monolayers were mock-infected or infected with the wild-type or mutant viruses at MOI = 1 for 1 h at 37°C. Then monolayers were washed briefly with PBS, fresh infection media (0.5% BSA in DMEM supplemented with 20 μM L-glutamine) was added and cells incubated at 37°C in 5% CO~2~ atmosphere for 12 or 15 h prior to RNA isolation or preparation of lysates for western blotting. For immunofluorescence microscopy analysis cells grown on glass coverslips were infected as described above and fixed at 15 h post-infection using 4% paraformaldehyde in PBS.

### Preparation of cell lysates containing biotinylated proteins {#sec4.4.4}

HEK293T cells grown on 10-cm dishes were washed briefly and transfected with BirA^∗^ fusion protein expression constructs using PEI. At 6 h post transfection, media was changed to 10% FBS DMEM supplemented with 50 μM biotin (Sigma). 24 h post-transfection (18 h post-biotin addition) cells were washed and collected in ice cold PBS, and centrifuged at 250 x *g* for 5 min at 4°C. Cell pellets were resuspended in 500 μl RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Igepal, 0.5% sodium deoxycholate, 0.1% SDS) with protease inhibitor cocktail (P8340, Sigma) and lysed at 4°C for 1 h with gentle agitation, followed by passing through a 21-gauge needle. Lysates were cleared by centrifugation at 4°C for 20 min at 20,000 x *g*.

### Neutravidin pull-down {#sec4.4.5}

60 μl of 50% slurry of High Capacity Neutravidin Agarose Beads (Thermo) was used for each 500 μl of clarified whole cell lysate. Beads were equilibrated in RIPA buffer by washing three times for 10 min at 4°C. In one of the BirA^∗^-X61 experimental runs, 1 μl of 500x RNase A (100 μg, QIAGEN) was added to each sample to remove non-specific interactors. The lysate was then incubated for 5 min at room temperature before loading onto the beads. Untreated samples were loaded directly onto the beads post washing. 1 mg of protein sample was loaded to beads in 1.5 ml Eppendorf tubes, which were then placed on a rotator overnight at 4°C, and collected with centrifugation at 400 x *g* for 1 min at 4°C. Beads were washed with RIPA buffer three times, followed by three washes with TAP buffer (50 mM HEPES-KOH pH 8.0, 100 mM KCl and 10% glycerol).

### Mass spectrometry sample preparation {#sec4.4.6}

Beads were resuspended in 50 mM triethylammonium bicarbonate (TEAB) buffer (Sigma). 24 mM DTT and 32 mM IAcNH2 were added sequentially. Beads were then incubated for 30 min at 37°C, washed with 50 mM TEAB and centrifuged for 1 min at 400 x *g* before resuspending in 50 mM TEAB. On-bead trypsin (Pierce Trypsin protease, MS-Grade; Thermo Scientific) digest was performed with 1 μg trypsin in 50 mM TEAB buffer, shaken overnight at 37°C. Samples were acidified with 1 μl trifluoroacetic acid (TFA) and 3 μl Formic acid until a pH lower than 3 was achieved. Trypsinized peptides were collected by puncturing a hole in the bottom of the 1.5 ml Eppendorf tube using a 30-gauge needle, placing it in a 2 ml Eppendorf tube and spinning it at 2000 rpm for 1 min at room temperature. Beads were washed with 50 mM TEAB prior to desalting. Samples were desalted with Oasis/SepPak Desalting columns, eluted sequentially in 1 ml 50% ACN/0.1% TFA and 500 μl 70% ACN/0.1% TFA. Combined eluted samples were dried in a Thermo SPDIIIV speed vacuum centrifuge and frozen at −20°C.

### Reductive dimethylation and quantitative mass spectrometry {#sec4.4.7}

Quantitative mass spectrometry analysis via reductive dimethylation enabled measurements of relative abundance of biotinylated proteins in each experimental condition ([@bib37]). In reductive dimethylation, formaldehyde molecules with different combinations of stable hydrogen and carbon isotopes are conjugated to peptide samples. Dried protein samples were resuspended by sonication for 15 min in 50 mM TEAB. BirA^∗^, BirA^∗^-XORF (X61 or X41) and BirA^∗^-X61(4A) samples were labeled with light, medium and heavy isotopes respectively. 8 μl formaldehyde (Sigma) were added to the light, 15 μl D2-formaldehyde (Cambridge Isotope Laboratories Inc.) to the medium and 15 μl D2-C13-formaldehyde (Aldrich) to the heavy samples. Reactions were incubated for 5 min at room temperature. Once incubation was completed, 0.51 M NaCNBH~3~ (sodium cyanoborohydride; Fluka) was added to the light and medium samples, while 0.51 M NaCNBD~3~ (sodium cyanoborodeuteride; Aldrich) was added to the heavy reaction, to label terminal amines. All three reactions were incubated for 1 h at room temperature before being combined into a single tube at a 1:1:1 ratio. The combined sample was acidified, desalted and dried as described above. Samples were resuspended in 3% ACN/0.1% formic acid and sonicated for 15 min to prepare for mass spectrometry. Mass spectrometry and peptide identification was performed at Dalhousie Proteomics CORE Facility by Dr. Alejandro Cohen (<https://medicine.dal.ca/research/mass-spectrometry-proteomics-and-metabolomics.html>). Proteome Discoverer software (Thermo) was used for protein identification. Functional Protein Association Network analysis was conducted on 29 selected protein hits using online STRING version 10.5 (<https://string-db.org/>) ([@bib75]).

### Cell fractionation for RNA analysis {#sec4.4.8}

Fractionation was performed as described previously ([@bib24]) with minor modifications. Briefly, cells were collected 24 h after transfection, centrifuged at 500 x *g* for 5 min at 4°C, then washed with PBS and counted. Equal numbers of cells were aliquoted into two tubes, one for the whole cell lysates collection and one for fractionation. Cells were pelleted again, and lysed on ice for 10 min in 250 μl ice-cold hypotonic lysis buffer (10 mM Tris pH 7.5, 10 mM NaCl, 3 mM MgCl~2~, 0.3% (vol/vol) NP-40, 10% (vol/vol) glycerol in nuclease-free water) supplemented with 100 U RNasin (Promega). For the whole cell lysate, Trizol (Life Technologies) was added directly to the lysate to extract RNA. For nuclear/cytoplasmic fraction, the lysate was centrifugated at 1000 x *g* for 3 min at 4°C to pellet membrane and nuclei. The supernatant was collected as the cytoplasmic fraction and Trizol was added to it to extract RNA. Finally, the nuclear pellet was washed 3 times with 1 ml hypotonic lysis buffer and collected by centrifugation at 200 x *g* for 2 min at 4°C, then lysed directly in Trizol to extract nuclear RNA.

### RNA purification, cDNA preparation and qPCR {#sec4.4.9}

For fractionation experiments, RNA was purified using Trizol. 1 ml Trizol, 2 μl glycogen and 200 μl chloroform (Fisher Scientific) were added to each fraction. Samples were then centrifuged at 16,000 x *g* for 15 min at 4°C, and the aqueous layer was collected. RNA was precipitated by addition of 700 μl isopropanol and incubation for 10 min at room temperature, followed by centrifugation at 16,000 x *g*, 4°C for 20 min. The pellet was washed with 75% ethanol, and resuspended in RNase-free water. For other transfection experiments, RNA was extracted from cells and purified using the Quick-RNA miniprep kit (Zymo Research), following manufacturer's protocol. In all cases, the RNA was treated with Turbo DNase (Life Technologies), then reverse transcribed using iScript supermix (Bio-Rad) per manufacturer's protocol. In the fractionation experiment, the same cell equivalents of total, nuclear and cytoplasmic fraction were used for these steps. qPCR was performed using iTaq Universal SYBR Green supermix (Bio-Rad), on the Bio-Rad CFX Connect Real-Time System qPCR and analyzed with Bio-Rad CFX Manager 3.1 program. The primers used are listed below.

### Intron splicing verification {#sec4.4.10}

Proper splicing of each intron for all IFN-λ2 construct was verified by PCR amplification across each splice sites using primers listed below. PCR products were run on a 2% agarose gel containing HydraGreen safe DNA dye (ACTGene) and imaged with a Syngene G:Box Chemi XT4 gel doc system.

### Co-immunoprecipitation from nuclear lysates {#sec4.4.11}

HEK293T_iPA-X-PR8 cells were plated in 10-cm dishes. Cells were then treated with 1 μg/ml doxycycline for 18 h to induce PA-X expression. Fractionation of nuclear lysates was performed as described previously ([@bib12]) with minor modifications. Briefly, cells were washed with ice-cold Dulbecco's PBS and centrifuged at 1,200 rpm for 6 min at 4°C to collect the cells. Cell pellets were lysed in 50 μl of a sucrose-based lysis buffer (0.32 M sucrose, 3 mM CaCl~2~, 2 mM MgOAc, 0.1 mM EDTA, 10 mM DTT, 0.5 mM PMSF). An additional 50 μl of sucrose lysis buffer with 0.5% (vol/vol) NP40 was added to the lysate. The lysate was centrifuged for 10 min at 1,100 x *g* at 4°C. The supernatant was collected as the cytoplasmic fraction, whereas the pellet was washed in 100 μl of sucrose lysis buffer, and centrifuged for 10 min at 2,000 rpm at 4°C. The supernatant was discarded and the pellet was lysed in 100 μl of Soluble Nuclear Lysis Buffer (50 mM HEPES pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 10% Glycerol, 1 mM DTT, 0.1 mM PMSF, cØmplete protease inhibitors (Roche)) and incubated on a rotating rotor at 4°C for 45 min. Samples were centrifuged at 10,000 x *g* for 3 min at 4°C. 20 μl of the supernatant was collected as the input sample, and the rest was added to myc-trap magnetic agarose beads (ChromoTek), or control magnetic agarose beads (ChromoTek) and incubated on a rotating rotor for 45 min at 4°C. Beads were collected on a magnetic rack and washed 6 times with wash buffer (50 mM Tris HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.05% NP40, cØmplete protease inhibitors (Roche)). 25 μl of Laemmli sample buffer was added to the beads, and samples were incubated for 10 min at 95°C prior to SDS-PAGE and western blotting.

### Western blotting and immunofluorescence {#sec4.4.12}

Western blotting and immunofluorescence were carried out as previously described ([@bib48], [@bib49]) using the antibodies listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. For detection of biotinylated proteins, HRP-conjugated streptavidin (Cell Signaling) and Alexa Fluor-488-conjugated streptavidin (Molecular Probes) were used.

### RNA-seq {#sec4.4.13}

For RNA-seq analysis of PA-X-expressing cells, A549 and A549 iPA-X cells were induced with 0.2 μg/ml doxycycline for 18 h. For RNA-seq analysis of infected cells, A549 cells were infected with PR8 wt, PA(fs), PA(X9), and PA(ΔX) viruses or mock infected for 15 h. Each condition was tested at least twice. RNA lysates were collected and purified using the RNeasy kit (QIAGEN). 650-750 ng of RNA were mixed with ERCC ExFold RNA spike-in mix (0.65 μl or 0.75 μl, respectively, Invitrogen/ThermoFisher) prior to the start of library preparation. The spike-in controls were included to better normalize the final RNA levels. This particular kit contains two mixes that can be used for the control versus test samples and that have known fold change differences. This information can be used to re-calibrate the samples. Prior to library preparation, the levels of select human mRNAs were tested by RT-qPCR, to confirm that PA-X overexpression/IAV infection had the expected effect. Libraries were prepared using the TruSeq Stranded Total RNA Library Prep Kit with Ribo-Zero Human (Illumina) following the manufacturer's protocol. Library preparation was evaluated using a Fragment Analyzer (Advanced Analytical Technologies, Inc.) at the Tufts University Core Facility - Genomics Core. High-throughput sequencing was carried out by the Tufts Genomics facility on a HiSeq 2500. Single-end 50 nucleotide reads were obtained with a multiplexing strategies, using a total of four lanes. For the replicates, the spike mixes for the samples and the barcoded primers were switched, in order to control for potential biases.

### Read alignment and bioinformatic analysis {#sec4.4.14}

Reads were aligned with Tophat2 v2.1.1 ([@bib51]) to hg19, IAV PR8 and the ERCC spike sequences. Default settings were used, except \--library-type fr-firststrand, and a gtf of the hg19 annotation was provided as reference. [Table S1](#mmc1){ref-type="supplementary-material"} summarizes the results of the alignment. FPKMs were computed using Cufflinks v2.2.1 ([@bib76]). Default settings were used, except \--library-type fr-firststrand and --u, and a gtf of the hg19 annotation was provided as reference. Only previously annotated RNAs with a level of \>1 FPKM in all the control samples (A549 + dox or mock-infected A549) were used in further analyses. Because most annotated RNAs are Pol II transcripts, the downstream analysis includes predominantly Pol II transcripts. The FPKMs for the RNAs were converted to attomoles of RNA based on the known concentration of the spike-in controls. [Table S2](#mmc1){ref-type="supplementary-material"} shows the high correlation in measured RNA levels between replicate samples. The absolute RNA levels in the replicates were averaged, and the relative RNA levels (RNA ratio) in infected versus mock infected or PA-X-expressing versus control cells was computed. All downstream analysis was carried out on the relative levels (ratio) in log2 scale. [Data S1](#mmc3){ref-type="supplementary-material"} and [S2](#mmc4){ref-type="supplementary-material"} include tables that summarize the results of the RNaseq analyses. The hg19 annotation was used to derive the number of exons, length of transcripts and GC content for the analyses in [Figures 4](#fig4){ref-type="fig"}, [S3](#mmc1){ref-type="supplementary-material"}. For analysis of intronless RNAs, only RNAs that were longer than 300 nt were used, to enrich for mRNAs and long non-coding RNAs and exclude small non-coding RNAs that are transcribed by Pol III or are produced through processing of longer transcripts, like microRNAs and small nuclear and nucleolar RNAs. The length distribution of the remaining intronless RNAs was similar to that of the spliced RNAs. All RNAs were used for the analysis of PA-X downregulation versus length, exon number, and GC content. *k*-means clustering analysis was carried out using the Cluster 3.0 program ([http://bonsai.hgc.jp/∼mdehoon/software/cluster/software.htm](http://bonsai.hgc.jp/%7Emdehoon/software/cluster/software.htm){#intref0160}). The clustering was done only on RNAs that were detected in all samples tested (6,391 RNAs), because all eight datasets were used to generate the clusters, even though only the mRNA levels for select samples are plotted in [Figures 3](#fig3){ref-type="fig"}A-C for clarity. The classified RNAs listed in [Data S1](#mmc3){ref-type="supplementary-material"}a, S1b, S1c and [S2](#mmc4){ref-type="supplementary-material"}a, S2b, S2c represent these 6,391 RNAs. Because in *k*-means clustering the number of clusters is user-defined, clustering was attempted with three, four, and five clusters. Four clusters were chosen, because they provided more granularity. For example, they identified a group of RNAs that were only PA-X-dependent in the ectopic expression system. Initializing the program with more than four clusters led to separation of PA-X targets in multiple groups different only by the extent of downregulation, but did not identify other patterns of gene expression. Gene ontology (GO) term analysis was carried out on the DAVID server ([@bib41], [@bib42]). The 5′ splice site quality score was computed using the MaxEntScan::score5ss program using the maximum entropy model ([@bib79]). Other analyses were done using custom scripts in Python2.7. For the ISG analysis ([Figure 3](#fig3){ref-type="fig"}E) the list of ISG tested by Schoggins et al. was used ([@bib71]).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

For [Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}C, [5](#fig5){ref-type="fig"}, [7](#fig7){ref-type="fig"}, [S4](#mmc1){ref-type="supplementary-material"}, [S6](#mmc1){ref-type="supplementary-material"}, statistical analysis and plotting were done in GraphPad Prism v7.0d software using the test recommended by the software and indicated in the figure legends. Generally, ANOVA followed by a corrected pairwise test (Tukey's or Dunnett's) was used when more than two samples were analyzed and Student's t test when two samples were compared. For [Figures 1](#fig1){ref-type="fig"}C and 1D, [2](#fig2){ref-type="fig"}A and 2B, [4](#fig4){ref-type="fig"}, statistical analysis and plotting were done using Python2.7 and the NumPy, SciPy and matplotlib libraries. The Kolmogorov-Smirnoff test was used to compare populations and Spearman's correlation coefficient to analyze the relationship between certain variables and RNA downregulation. Statistical tests used for each panel are noted in Figure legends and/or Figures.

Data and Software Availability {#sec4.6}
------------------------------

The accession number for the RNA-seq data reported in this paper is GEO: [GSE120183](ncbi-geo:GSE120183){#intref0165} (raw read data and processed data included here as [Data S1](#mmc3){ref-type="supplementary-material"} and [S2](#mmc4){ref-type="supplementary-material"}).

Supporting Citations {#app3}
====================

The following references appear in the Supplemental Information: [@bib2], [@bib3], [@bib4], [@bib21], [@bib38], [@bib59], [@bib77].

Supplemental Information {#app2}
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Document S1. Figures S1--S6 and Tables S1--S3 Table S4. Summary of BioID Results, Related to Figure 6List of proteins identified in each experimental run and of the 29 high-confidence hits Data S1. Relative RNA Levels in IAV-Infected Cells, Related to Figures 1 and 2Includes four tab-delimited .txt tables summarizing the relative RNA levels from RNAseq analysis in IAV-infected versus mock infected cells for all four IAV strains used (fold-changes from replicate averages and standard deviations). S1all = all RNAs. S1a = PA-X targets based on clustering analysis (Figure 3A). S1b = PA-X resistant RNAs based on clustering analysis (Figure 3B). S1c = RNAs regulated by other processes during infection based on clustering analysis (Figure 3C). Data S2. Relative RNA Levels in PA-X-Expressing Cells, Related to Figures 1 and 2Includes four tab-delimited .txt tables summarizing the relative RNA levels from RNAseq analysis in PA-X-expressing versus control cells for all four iPA-X cell lines used (fold-changes from replicate averages and standard deviations). S2all = all RNAs. S2a = PA-X targets based on clustering analysis (Figure 3A). S2b = PA-X resistant RNAs based on clustering analysis (Figure 3B). S2c = RNAs that are regulated by other processes during infection based on clustering analysis (Figure 3C). Document S2. Article plus Supplemental Information
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